One-and-done COVID-19 drug successful
A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.
New way to treat COVID-19 smell loss
In a trial led by Stanford Medicine researchers, more than half of patients with persistent smell loss saw improvement with injections of platelet-rich plasma.
How COVID-19 virus infects nasal cells
A discovery by Stanford Medicine researchers and colleagues may pave the way for a “morning after” or prophylactic nasal spray to prevent infection.
Predicting immunity from vaccination
A gene signature seen in antibody-producing cells in the blood of vaccinated study participants could expedite vaccine development.
Awards for COVID-19 project, media work
A COVID-19 remembrance project, two videos, an article about bad brain cells and Stanford Medicine magazine have been recognized by the Council for Advancement and Support of Education.
Antivirals may benefit some inpatients
Elevated virus levels in hospitalized COVID-19 patients’ blood predicts worsening respiratory symptoms and suggests ongoing viral replication in later disease stages, Stanford Medicine-led study says.
COVID-19 virus can infect fat tissue
Stanford Medicine scientists’ findings could explain why obese people have a higher risk of SARS-CoV-2 infection and are more likely to progress to severe disease and die of infection.
Viral genome packing key in replication
Disrupting a virus’s genome packaging can halt replication and jumpstart a natural immune response against subsequent exposures, a Stanford Medicine study finds.
Mark Davis on immunology research
Vaccinology has taken great leaps forward in the past decade, largely due to advanced analytical methods as well as a shift in researchers’ focus from rodents to humans.
Hints into long COVID
People with lower levels of an antiviral antibody as well as those with lung disease take longer to clear COVID-19 symptoms, say Stanford Medicine researchers.
Gummy phlegm and COVID-19
Levels of a stringy, spongy substance soar in the sputum of COVID-19 patients requiring intubation, accounting for at least some of their breathing trouble. Development of an off-patent drug may prevent it.
Stanford Medicine COVID-19 Updates
Stanford COVID-19 Health Alerts
Stanford Medicine COVID-19 Guide for First Responders and Essential Workers
Curated Tracker of Treatment & Vaccine Development for COVID-19
Stanford Health Care COVID-19 Resource Center
- Big Data
- Cardiovascular Health
- Chemical Biology
- Chronic Disease
- Developmental Biology
- Global Health
- Health Policy
- Infectious Disease
- Mental Health
- Patient Care
- Precision Health
- Preventive Medicine
- Stem Cells
- Women's Health